BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35335887)

  • 1. Honeybee Venom Synergistically Enhances the Cytotoxic Effect of CNS Drugs in HT-29 Colon and MCF-7 Breast Cancer Cell Lines.
    Duarte D; Falcão SI; El Mehdi I; Vilas-Boas M; Vale N
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs.
    Duarte D; Cardoso A; Vale N
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.
    Duarte D; Nunes M; Ricardo S; Vale N
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Strategies for Cancer Combat: Drug Combination Using Repurposed Drugs Induces Synergistic Growth Inhibition of MCF-7 Breast and HT-29 Colon Cancer Cells.
    Duarte D; Guerreiro I; Vale N
    Curr Issues Mol Biol; 2022 Oct; 44(10):4930-4949. PubMed ID: 36286050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells.
    Duarte D; Rêma A; Amorim I; Vale N
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of the In Vitro Cytotoxic Effect on HT-29 Colon Cancer Cells by Combining 5-Fluorouacil and Fluphenazine with Green, Red or Brown Propolis.
    Falcão SI; Duarte D; Diallo M; Santos J; Ribeiro E; Vale N; Vilas-Boas M
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells.
    Duarte D; Vale N
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33271968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical characterization, antioxidant, anti-inflammatory and cytotoxic properties of bee venom collected in Northeast Portugal.
    Sobral F; Sampaio A; Falcão S; Queiroz MJ; Calhelha RC; Vilas-Boas M; Ferreira IC
    Food Chem Toxicol; 2016 Aug; 94():172-7. PubMed ID: 27288930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bee Venom Components as Therapeutic Tools against Prostate Cancer.
    Badawi JK
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34067049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
    Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
    Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Effects Induced by Combined Treatments of Aqueous Extract of Propolis and Venom.
    Drigla F; Balacescu O; Visan S; Bisboaca SE; Berindan-Neagoe I; Marghitas LA
    Clujul Med; 2016; 89(1):104-9. PubMed ID: 27004032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers.
    Pandey P; Khan F; Khan MA; Kumar R; Upadhyay TK
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First Characterization of The Venom from
    Frangieh J; Salma Y; Haddad K; Mattei C; Legros C; Fajloun Z; El Obeid D
    Toxins (Basel); 2019 Mar; 11(4):. PubMed ID: 30935025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches.
    Vale N; Pereira M; Santos J; Moura C; Marques L; Duarte D
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin and Nitrofurantoin Repurposed in the Context of Breast Cancer and Neuroblastoma Cells.
    Moura C; Correia AS; Pereira M; Ribeiro E; Santos J; Vale N
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Surprising Repurposing of Central Nervous System Drugs against Squamous Cell Carcinoma of the Bladder, UM-UC-5.
    Gouveia MJ; Ribeiro E; Vale N
    Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
    Bjelogrlić SK; Srdić T; Radulović S
    J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells.
    Khamis AAA; Ali EMM; El-Moneim MAA; Abd-Alhaseeb MM; El-Magd MA; Salim EI
    Biomed Pharmacother; 2018 Sep; 105():1335-1343. PubMed ID: 30021371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Fucoidan and Chemotherapeutic Agent Combinations on Malignant and Non-malignant Breast Cell Lines.
    Abudabbus A; Badmus JA; Shalaweh S; Bauer R; Hiss D
    Curr Pharm Biotechnol; 2017; 18(9):748-757. PubMed ID: 29141543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.
    Novais MVM; Gomes ER; Miranda MC; Silva JO; Gomes DA; Braga FC; Pádua RM; Oliveira MC
    Biomed Pharmacother; 2021 Apr; 136():111123. PubMed ID: 33486211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.